Arundhati Nag

This inventor holds 14 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 4 EPO patents, primarily in Biotechnology Innovations. Top assignees: California Institute of Technology, Indi Molecular, Inc., Regeneron Pharmaceuticals, Inc.. Active years: 2014-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Arundhati Nag. Retrieved from https://idiyas.com/inventor/arundhati-nag

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 14 (Patent Applications = 4)

% Patents Active = 100.0

CIPO Patents = 1

EPO Patents = 4 (Patent Applications = 5)

Average Co-Inventor Count = 6.0

ph-index = 4

Forward Citations = 45(Granted Patents)

Company Filing History:

9 out of 4,633

California Institute of Technology

Regeneron Pharmaceuticals, Inc.

patents

where one patent can have more than one assignee

Years Active: 2014-2026

Loading Chart...

Areas of Expertise:

IL-17 Capture Agents

Cyclic Peptides

Oncogenic K-Ras

Akt-Specific Agents

Protein Targeting

Biocompatible Compositions

Cancer Therapeutics

Phosphorylated Proteins

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12546785 - IL-17F AND IL-17A-SPECIFIC CAPTURE AGENTS, COMPOSITIONS, AND METHODS OF USING AND MAKING (2026-02-10),

2. 12517136 - IL-17F-SPECIFIC CAPTURE AGENTS, COMPOSITIONS, AND METHODS OF USING AND MAKING (2026-01-06),

3. 12480950 - AKT-SPECIFIC CAPTURE AGENTS, COMPOSITIONS, AND METHODS OF USING AND MAKING (2025-11-25),

4. 11719705 - IL-17F and IL-17A-specific capture agents, compositions, and methods of using and making (2023-08-08),

5. 11371994 - Phosphorylated Akt-specific capture agents, compositions, and methods of using and making (2022-06-28),

6. 11365219 - Cyclic peptides as protein targeting agents (2022-06-21),

7. 11168115 - Cyclic peptides as protein targeting agents (2021-11-09),

8. 10913774 - Cyclic peptide binder against oncogenic K-Ras (2021-02-09),

9. 10598671 - IL-17F-specific capture agents, compositions, and methods of using and making (2020-03-24),

10. 10221214 - Akt-specific capture agents, compositions, and methods of using and making (2019-03-05),

11. 10017540 - Cyclic peptide binder against oncogenic K-Ras (2018-07-10),

12. 9239332 - Akt-specific capture agents, compositions, and methods of using and making (2016-01-19),

13. 9188584 - Capture agents and related compositions, methods and systems (2015-11-17),

14. 8906830 - Capture agents and related compositions, methods and systems (2014-12-09),

Title: Arundhati Nag: Innovator in Biochemical Detection Agents

Introduction

Arundhati Nag is a prominent inventor based in Pasadena, CA, known for her significant contributions to the field of biochemical detection agents. With a total of 11 patents to her name, she has made remarkable advancements in the development of capture agents that are crucial for medical diagnostics and treatment.

Latest Patents

Among her latest patents are the IL-17F and IL-17A-specific capture agents, compositions, and methods of using and making. This application provides stable peptide-based IL-17F and IL-17A capture agents and methods of use as detection agents. Additionally, it outlines methods for manufacturing IL-17F capture agents. Another notable patent is for phosphorylated Akt-specific capture agents, compositions, and methods of using and making. This application also provides stable peptide-based Akt capture agents and methods of use as detection and diagnosis agents, as well as in the treatment of diseases and disorders. It further details methods for manufacturing Akt capture agents using iterative on-bead in situ click chemistry.

Career Highlights

Arundhati has worked with esteemed organizations such as the California Institute of Technology and Indi Molecular, Inc. Her work in these institutions has allowed her to push the boundaries of innovation in her field.

Collaborations

Throughout her career, Arundhati has collaborated with notable individuals, including James R. Heath and Samir Das. These collaborations have contributed to her success and the advancement of her research.

Conclusion

Arundhati Nag is a trailblazer in the development of biochemical detection agents, with a strong portfolio of patents that reflect her innovative spirit. Her contributions continue to impact the field of medical diagnostics and treatment.

Profile summary based on public USPTO records.